Previous studies have also implicated EPHA3 in angiogenesis and invasive pathways in various cancers, further supporting the hypothesis that HOC-mediated suppression of EPHA3 contributes to reduced tumor recurrence and aggressiveness observed in this study model [5,6]. The gene discussed is EPHA3; the disease is cancer.